STOCK TITAN

Insider reports sales and vesting at FTRE (NASDAQ: FTRE)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Mark A. Morais reported insider transactions involving Common stock of FTRE. The filing lists a proposed sale tied to 03/13/2026 described as Restricted Stock Vesting (issuer/compensation). It also records sales of 1,179 shares on 02/10/2026 and 4,599 shares on 03/10/2026.

Positive

  • None.

Negative

  • None.

Insights

Routine insider activity: vesting plus recent dispositions of common shares.

The filing documents a compensation-related vesting event dated 03/13/2026 and two reported share dispositions: 1,179 shares on 02/10/2026 and 4,599 shares on 03/10/2026. These items are typical entries on a Form 144/144-style insider notice.

Cash-flow treatment and trading venue are not specified in the provided excerpt; subsequent filings or broker reports would show execution details if relevant. The immediate investor signal is limited given the compensation origin of the vested shares.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What transactions did Mark A. Morais report on the FTRE Form 144?

He reported a restricted stock vesting event on 03/13/2026 and two sales: 1,179 shares on 02/10/2026 and 4,599 shares on 03/10/2026. The filing lists these items under securities sold and vesting.

Was the 03/13/2026 entry for FTRE a sale or compensation vesting?

The entry dated 03/13/2026 is described as Restricted Stock Vesting and is labeled under compensation. It is recorded as an issuer-related vesting event, not explicitly a sale in that line.

Do the FTRE filings state how the sold shares were executed or who received proceeds?

The provided excerpt does not specify execution method or proceeds recipient. It lists the sale dates and share counts but does not disclose venue, prices, or cash-flow treatment in the visible content.

How should investors interpret these Form 144 entries for FTRE?

These entries show a compensation vesting and recent dispositions of shares by Mark A. Morais: 1,179 and 4,599 shares on specified dates. They are factual disclosures; the filing itself does not state intent or provide broader company financial context.
Fortrea Holdings

NASDAQ:FTRE

View FTRE Stock Overview

FTRE Rankings

FTRE Latest News

FTRE Latest SEC Filings

FTRE Stock Data

866.75M
92.98M
Biotechnology
Services-medical Laboratories
Link
United States
DURHAM